New drug may change treatment of heart failure

Aired: 8/31/2014 | 0:04:06 | Clip
An experimental heart drug developed by the Swiss pharmaceutical company Novartis shows promising results. The new drug, currently referred to as “L C Z 696” may change the course of treatment and prolong the lives of patients suffering from heart failure. For some insight, Dr. Clyde Yancy from Northwestern University joins Hari Sreenivasan via Skype from Windham, New Hampshire.